UBS AM
KOD icon

UBS AM’s Kodiak Sciences KOD Stock Holding History

UBS AM’s Portfolio KOD Stock Details KOD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.62M Sell
41,551
-2,200
-5% -$85.6K ﹤0.01% 2150
2026
Q1 		$1.67M Buy
43,751
+43,558
+22,569% +$1.13M ﹤0.01% 2127
2025
Q4 		$5.4K Buy
+193
New +$3.95K ﹤0.01% 2967
2023
Q3 		– Sell
-59,558
Closed -$369K – 2647
2023
Q2 		$369K Hold
59,558
– – ﹤0.01% 2412
2023
Q1 		$369K Sell
59,558
-18,740
-24% -$131K ﹤0.01% 2412
2022
Q4 		$561K Hold
78,298
– – ﹤0.01% 2136
2022
Q3 		$606K Buy
78,298
+24,635
+46% +$239K ﹤0.01% 2257
2022
Q2 		$410K Buy
53,663
+15,041
+39% +$106K ﹤0.01% 2371
2022
Q1 		$298K Buy
38,622
+6,871
+22% +$268K ﹤0.01% 2596
2021
Q4 		$2.69M Buy
31,751
+557
+2% +$56.7K ﹤0.01% 1729
2021
Q3 		$2.99M Hold
31,194
– – ﹤0.01% 1640
2021
Q2 		$2.9M Buy
31,194
+545
+2% +$52.3K ﹤0.01% 1680
2021
Q1 		$3.48M Sell
30,649
-5,160
-14% -$705K ﹤0.01% 1510
2020
Q4 		$5.26M Buy
35,809
+10,043
+39% +$1.12M ﹤0.01% 1272
2020
Q3 		$1.53M Buy
25,766
+250
+1% +$12.5K ﹤0.01% 1663
2020
Q2 		$1.38M Buy
25,516
+6,704
+36% +$378K ﹤0.01% 1671
2020
Q1 		$897K Buy
18,812
+1,272
+7% +$76.3K ﹤0.01% 1734
2019
Q4 		$1.26M Buy
+17,540
New +$638K ﹤0.01% 1802

Other funds holding KOD

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

UBS AM's KOD Position: Q2 2026 in Review

UBS AM reduced its Kodiak Sciences (KOD) stake by 5% in Q2 2026, selling an estimated $85.6K and leaving 41,551 shares worth $1.62M. The position accounts for ﹤0.01% of the portfolio, ranked #2150.

UBS AM first reported a position in KOD in Q4 2019 and has held it in 18 quarters since. The position peaked at $5.26M in Q4 2020. 199 funds tracked by Wall St. Rank hold KOD as of Q2 2026.

  • UBS AM held 41,551 shares of Kodiak Sciences worth $1.62M as of Q2 2026.
  • UBS AM sold 2,200 Kodiak Sciences shares in Q2 2026, an estimated $85.6K.
  • Kodiak Sciences made up ﹤0.01% of UBS AM's portfolio in Q2 2026, its #2150 holding.
  • UBS AM first reported a position in Kodiak Sciences in Q4 2019 and has held it in 18 quarters since.
  • UBS AM's Kodiak Sciences position peaked at $5.26M in Q4 2020.
  • 199 funds tracked by Wall St. Rank held Kodiak Sciences as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.